Tresiba, a daily basal insulin injection ... with promising results also annouced for its oral drug Semaglutide. One of the first acts of President Donald Trump after his inauguration yesterday ...

Crucially, the long-acting insulin was no worse than Tresiba when it came to rates of ... versus 0.27 events for the once-daily drug. Novo Nordisk said that if approved for use, insulin icodec ...